The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 02, 2021

Filed:

Dec. 02, 2016
Applicants:

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Children's Medical Center Corporation, Boston, MA (US);

Inventors:

Dhvanit I. Shah, Malden, MA (US);

George Q. Daley, Weston, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/02 (2006.01); C12N 5/071 (2010.01); C12N 5/0789 (2010.01); A61K 35/28 (2015.01); A01K 67/027 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0647 (2013.01); A01K 67/0271 (2013.01); A61K 35/28 (2013.01); A01K 2207/12 (2013.01); C12N 2501/999 (2013.01); C12N 2506/00 (2013.01); C12N 2506/28 (2013.01); C12N 2506/45 (2013.01); C12N 2533/52 (2013.01);
Abstract

Described in the present application are methods for preparing populations of hematopoietic stem cells (HSCs), e.g., autologous and/or allogenic HSCs, using mechanical stretching or Trpv4 agonisists, and methods of use of the HSCs in transplantation. In some embodiments, the methods include providing a population comprising hemogenic endothelial (HE) cells, and (i) contacting the HE cells with an amount of an agonist of transient receptor potential cation channel-subfamily vanilloid member 4 (Trpv4); and/or (ii) subjecting the cells to cyclic 2-dimensional stretching, for a time and under conditions sufficient to stimulating endothelial-to-HSC transition. Also provided herein are methods for treating subjects who have, bone marrow, metabolic, and immune diseases; the methods include administering to the subject a therapeutically effective amount of hematopoietic stem cells (HSCs) obtained by a method described herein.


Find Patent Forward Citations

Loading…